The Journal of Pediatrics
Volume 154, Issue 3 , Pages 420-425.e1 , March 2009

Health-Related Quality of Life in Children with Neurofibromatosis Type 1: Contribution of Demographic Factors, Disease-Related Factors, and Behavior

  • Lianne C. Krab, MSc

      Affiliations

    • NF1 CoRe Team (Cognitive Research Team), Department of General Pediatrics, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
    • NF1 CoRe Team (Cognitive Research Team), Department of Neuroscience, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
    • ,
  • R. Oostenbrink, MD, PhD

      Affiliations

    • NF1 CoRe Team (Cognitive Research Team), Department of General Pediatrics, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
    • ,
  • Arja de Goede-Bolder, MD

      Affiliations

    • NF1 CoRe Team (Cognitive Research Team), Department of General Pediatrics, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
    • ,
  • Femke K. Aarsen, MA

      Affiliations

    • NF1 CoRe Team (Cognitive Research Team), Department of Pediatric Neurology, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
    • ,
  • Ype Elgersma, PhD

      Affiliations

    • NF1 CoRe Team (Cognitive Research Team), Department of Neuroscience, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
    • ,
  • Henriëtte A. Moll, MD, PhD

      Affiliations

    • NF1 CoRe Team (Cognitive Research Team), Department of General Pediatrics, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands
    • Corresponding Author InformationReprint requests: Prof. Dr. H.A. Moll, Department of General Pediatrics, Erasmus MC–Sophia Children's Hospital, PO Box 2060, 3000 CB Rotterdam, The Netherlands

Received 9 April 2008 ,Revised 2 July 2008 ,Accepted 26 August 2008.

References 

  1. Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales (I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity). J Med Genet. 1989;26:704–711
  2. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81–88
  3. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet. 1999;89:45–52
  4. Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, et al. Impact of Neurofibromatosis type 1 on School Performance. J Child Neurol doi: 10.1177/0883073808316366.
  5. Johnson NS, Saal HM, Lovell AM, Schorry EK. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr. 1999;134:767–772
  6. Dilts CV, Carey JC, Kircher JC, Hoffman RO, Creel D, Ward K, et al. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J Dev Behav Pediatr. 1996;17:229–239
  7. Barton B, North K. Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol. 2004;46:553–563
  8. Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005;65:1037–1044
  9. Descheemaeker MJ, Ghesquiere P, Symons H, Fryns JP, Legius E. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children. J Intellect Disabil Res. 2005;49:33–46
  10. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol. 2001;137:1421–1425
  11. Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P. Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases. Am J Med Genet A. 2006;140:1893–1898
  12. Oostenbrink R, Spong K, de Goede-Bolder A, Landgraf JM, Raat H, Moll HA. Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants. J Pediatr. 2007;151:182–1866 e1-2
  13. Graf A, Landolt MA, Mori AC, Boltshauser E. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. J Pediatr. 2006;149:348–353
  14. Krab LC, De Goede-Bolder A, Aarsen FK, Pluijm SM, Bouman MJ, Van der Geest JN, et al. Effect of Simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA. 2008;300:287–294
  15. Landgraf J, Abetz L, JE W. The CHQ user's manual. Boston: The Health Institute, New England Medical Center; 1996;
  16. Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJ. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol. 2002;55:67–76
  17. Raat H, Landgraf JM, Bonsel GJ, Gemke RJ, Essink-Bot ML. Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res. 2002;11:575–581
  18. Divisie Sociale en Ruimtelijke statistieken, Sector Ontwikkeling en ondersteuning. Standaard Beroepenclassificatie 1992. Voorburg/Heerlen: Centraal Bureau voor de Statistiek; 2001;ed.
  19. Ablon J. Gender response to neurofibromatosis 1. Soc Sci Med. 1996;42:99–109
  20. Friedman JM, Gutmann DH, Maccollin M, Riccardi VM. Neurofibromatosis: phenotype, natural history, and pathogenesis. 3rd ed.. Baltimore: The Johns Hopkins University Press; 1999;
  21. Achenbach TM. Integrative guide for the CBCL/4-8, YRS and TRF profiles. Burlington, VT: University of Vermont Department of Psychiatry; 1991;
  22. Raat H, Landgraf JM, Oostenbrink R, Moll HA, Essink-Bot ML. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res. 2007;16:445–460
  23. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1977;
  24. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174
  25. Vogels T, Verrips GHW, Koopman HM, Theunissen NCM, Fekkes M, Kamphuis RP. TACQOL manual: parent form and child form. Leiden: Leiden Center for Child Health and Pediatrics LUMC-TNO; 2000;
  26. Zoller ME, Rembeck B. A psychiatric 12-year follow-up of adult patients with neurofibromatosis type 1. J Psychiatr Res. 1999;33:63–68
  27. Barton B, North K. The self-concept of children and adolescents with neurofibromatosis type 1. Child Care Health Dev. 2007;33:401–408
  28. Sebold CD, Lovell A, Hopkin R, Noll R, Schorry E. Perception of disease severity in adolescents diagnosed with neurofibromatosis type 1. J Adolesc Health. 2004;35:297–302
  29. Heath NL, Glen T. Positive illusory bias and the self-protective hypothesis in children with learning disabilities. J Clin Child Adolesc Psychol. 2005;34:272–281
  30. Hoza B, Pelham WE, Dobbs J, Owens JS, Pillow DR. Do boys with attention-deficit/hyperactivity disorder have positive illusory self-concepts?. J Abnorm Psychol. 2002;111:268–278
  31. White-Koning M, Arnaud C, Bourdet-Loubere S, Bazex H, Colver A, Grandjean H. Subjective quality of life in children with intellectual impairment—how can it be assessed?. Dev Med Child Neurol. 2005;47:281–285
  32. Klassen AF, Miller A, Fine S. Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder. Child Care Health Dev. 2006;32:397–406
  33. White-Koning M, Arnaud C, Dickinson HO, Thyen U, Beckung E, Fauconnier J, et al. Determinants of child-parent agreement in quality-of-life reports: a European study of children with cerebral palsy. Pediatrics. 2007;120:e804–e814
  34. von Rueden U, Gosch A, Rajmil L, Bisegger C, Ravens-Sieberer U. Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study. J Epidemiol Community Health. 2006;60:130–135
  35. Mautner VF, Kluwe L, Thakker SD, Leark RA. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol. 2002;44:164–170

 Supported by a grant from the Hersenstichting Nederland to L.C.K. and Y.E., by a grant from the Sophia Foundation for Medical Research to L.C.K., H.A.M and Y.E., and by a donation from the Dutch Neurofibromatosis Foundation (NFVN). The study sponsors had no role in the study design, the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the manuscript for publication. The authors declare no potential, real, or perceived conflicts of interest.

PII: S0022-3476(08)00760-9

doi: 10.1016/j.jpeds.2008.08.045

The Journal of Pediatrics
Volume 154, Issue 3 , Pages 420-425.e1 , March 2009

Article Tools

* Image Usage & Resolution